Cullinan Therapeutics, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Cullinan Therapeutics, Inc. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Cullinan Therapeutics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
  • Cullinan Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $5.4M.
  • Cullinan Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $0.000.
Deferred Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.4M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.